                            stdClass Object
(
    [post_id] => 1054
    [category_id] => 4
    [id] => 4
    [language_code] => en
    [title] => News
    [description] => News
    [slug] => news
    [meta_title] => News
    [meta_description] => News
    [meta_keyword] => News
    [content] => 
    [parent_id] => 0
    [thumbnail] => 
    [banner] => trang_chu/tt_xn/gioi_thieu_ttxn_gentis_(10).jpg
    [is_featured] => 
    [files] => 
    [style] => 
    [class] => 
    [type] => post
    [order] => 1
    [is_status] => 1
    [created_time] => 2019-08-24 10:39:48
    [updated_time] => 2021-09-07 13:05:32
    [created_by] => 
    [updated_by] => 
    [ratting] => 
    [retionship] => 
    [question] => 
    [url_video] => 
    [link] => 
    [i_con] => 
)
1

Workshop to introduce new service 2023 at Nam Hoc and Rarely Hospital in Hanoi

Created date : 13-02-2023

Updated date: 23-08-2023

Author: Gentis

On January 12, 2023, GENTIS participated in reporting and updating GENTIS's upcoming projects and plans to the medical team working at Hanoi Nam Hoc and Rare Hospital.

With the desire to cooperate and develop in-depth research on many new services, GENTIS Company has organized a sharing session with Hanoi Nam Hoc and Rarely Hospital. The report session was attended by more than 25 doctors and nurses from the leadership board, deputy head of department and doctors working at the Hospital. Especially on the GENTIS side, there were the participation of Dr. - R&D Director Pham Dinh Minh, Director of Testing Center Nguyen Quang Vinh and members of the department.

At the exchange, Dr. Pham Dinh Minh had a detailed report on new tests that are currently being researched, developed and of great significance in assisted reproduction, including:
• Project 1: Test to detect FSH gene variant that causes underresponsiveness and overstimulation of ovarian response
• Project 2: Research on combining genetic analysis of culture environment and morphology in embryo quality assessment
• Project 3: Rare disease PGT-M test kits to detect single gene disease (13 pathological genes)
• Project 4: Transfer of mosaic embryos
• Project 5: Fertiscan, screening, detection of genetic abnormalities causing male/female VSHM, and embryonic development block”

Through the report, the doctors of Hanoi Hospital of Andrology and Infertility have gained information, research directions, and implementation of new projects in 2023.

Doctors at the hospital had a lively discussion about the useful tests that are about to be implemented and how to access the service to suit the patient's infertility treatment. In addition, suggestions and opinions have been contributed to help GENTIS's test expand and develop in a way that is more suitable to the needs of patients.

After the scientific session, GENTIS and Hanoi Hospital of Andrology have come up with many useful cooperation proposals to jointly research and develop the application of high-tech testing in clinical practice. ready to contribute to the diagnosis and treatment of infertility and infertility today.
The seminar is an opportunity to exchange expertise that is highly appreciated by doctors, helping the research, cooperation and actual treatment of patients to soon achieve great progress, helping infertile cases. shorten the time with the most accurate treatment direction.